Yasuyoshi Watanabe

Prof. Dr. Yasuyoshi Watanabe

RIKEN Center for Biosystems Dynamics Research, Kōbe, Hyōgo, Japan
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2014 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
YNYasuhito Nakatomi
Yasuhito Nakatomi
KMKei Mizuno
Kei Mizuno
AIAkira Ishii
Akira Ishii
YWYasuhiro Wada
Yasuhiro Wada
MTMasaaki Tanaka
Masaaki Tanaka
Yasuyoshi WatanabeYasuyoshi Watanabe
Yasuyoshi Watanabe
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a disease characterized by chronic, profound, disabling, and unexplained fatigue. Although it is hypothesized that brain inflammation is involved in the pathophysiology of CFS/ME, there is no direct evidence of neuroinflammation in patients with CFS/ME. Activation of microglia or astrocytes is related to neuroinflammation. 11C-(R)-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline-carboxamide (11C-(R)-PK11195) is a ligand of PET for a translocator protein that is expressed by activated microglia or astrocytes. We used 11C-(R)-PK11195 and PET to investigate the existence of neuroinflammation in CFS/ME patients. Methods: Nine CFS/ME patients and 10 healthy controls underwent 11C-(R)-PK11195 PET and completed questionnaires about fatigue, fatigue sensation, cognitive impairments, pain, and depression. To measure the density of translocator protein, nondisplaceable binding potential (BPND) values were determined using linear graphical analysis with the cerebellum as a reference region. Results: The BPND values of 11C-(R)-PK11195 in the cingulate cortex, hippocampus, amygdala, thalamus, midbrain, and pons were 45%–199% higher in CFS/ME patients than in healthy controls. In CFS/ME patients, the BPND values of 11C-(R)-PK11195 in the amygdala, thalamus, and midbrain positively correlated with cognitive impairment score, the BPND values in the cingulate cortex and thalamus positively correlated with pain score, and the BPND value in the hippocampus positively correlated with depression score. Conclusion: Neuroinflammation is present in widespread brain areas in CFS/ME patients and was associated with the severity of neuropsychologic symptoms. Evaluation of neuroinflammation in CFS/ME patients may be essential for understanding the core pathophysiology and for developing objective diagnostic criteria and effective medical treatments.

1 January 2011 in Behavioral and Brain Functions
Verified
Journal Article
Open access
PDF file
KMKei Mizuno
Kei Mizuno
MTMasaaki Tanaka
Masaaki Tanaka
KYKouzi Yamaguti
Kouzi Yamaguti
OKOsami Kajimoto
Osami Kajimoto
HKHirohiko Kuratsune
Hirohiko Kuratsune
Yasuyoshi WatanabeYasuyoshi Watanabe
Yasuyoshi Watanabe
It is known that chronic fatigue is associated with sympathetic hyperactivity. However, the relationship between autonomic function and mental fatigue caused by a prolonged mental load in healthy humans is still unclear. Thus, in order to clarify the mechanisms underlying mental fatigue, we examined the association between mental fatigue and autonomic functions.

1 January 2012 in Behavioral and Brain Functions
Verified
Journal Article
Open access
PDF file
MTMasaaki Tanaka
Masaaki Tanaka
YSYoshihito Shigihara
Yoshihito Shigihara
AIAkira Ishii
Akira Ishii
MFMasami Funakura
Masami Funakura
EKEtsuko Kanai
Etsuko Kanai
Yasuyoshi WatanabeYasuyoshi Watanabe
Yasuyoshi Watanabe
Fatigue can be classified as mental and physical depending on its cause, and each type of fatigue has a multi-factorial nature. We examined the effect of mental fatigue on the central nervous system using electroencephalography (EEG) in eighteen healthy male volunteers.

12 March 2015 in EJNMMI Research
Verified
Journal Article
Open access
PDF file
HKHiroaki Kurihara
Hiroaki Kurihara
AHAkinobu Hamada
Akinobu Hamada
MYMasayuki Yoshida
Masayuki Yoshida
SSSchuichi Shimma
Schuichi Shimma
JHJun Hashimoto
Jun Hashimoto
KTKenji Tamura
Kenji Tamura
The purpose of this study was to determine whether brain metastases from HER2-positive breast cancer could be detected noninvasively using positron emission tomography (PET) with 64Cu-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-trastuzumab. PET was performed on five patients with brain metastases from HER2-positive breast cancer, at 24 or 48 h after the injection of approximately 130 MBq of the probe 64Cu-DOTA-trastuzumab. Radioactivity in metastatic brain tumors was evaluated based on PET images in five patients. Autoradiography, immunohistochemistry (IHC), and liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis were performed in one surgical case to confirm HER2 specificity of 64Cu-DOTA-trastuzumab. Metastatic brain lesions could be visualized by 64Cu-DOTA-trastuzumab PET in all of five cases, which might indicated that trastuzumab passes through the blood-brain barrier (BBB). The HER2 specificity of 64Cu-DOTA-trastuzumab was demonstrated in one patient by autoradiography, immunohistochemistry, and LC-MS/MS. Cu-DOTA-trastuzumab PET could be a potential noninvasive procedure for serial identification of metastatic brain lesions in patients with HER2-positive breast cancer. UMIN000004170

1 November 2015 in The Journal of Physiological Sciences
Verified
Journal Article
Open access
PDF file
MTMasaaki Tanaka
Masaaki Tanaka
STSeiki Tajima
Seiki Tajima
KMKei Mizuno
Kei Mizuno
AIAkira Ishii
Akira Ishii
YKYukuo Konishi
Yukuo Konishi
Yasuyoshi WatanabeYasuyoshi Watanabe
Yasuyoshi Watanabe
Fatigue is defined as a condition or phenomenon of decreased ability and efficiency of mental and/or physical activities, caused by excessive mental or physical activities, diseases, or syndromes. It is often accompanied by a peculiar sense of discomfort, a desire to rest, and reduced motivation, referred to as fatigue sensation. Acute fatigue is a normal condition or phenomenon that disappears after a period of rest; in contrast, chronic fatigue, lasting at least 6 months, does not disappear after ordinary rest. Chronic fatigue impairs activities and contributes to various medical conditions, such as cardiovascular disease, epileptic seizures, and death. In addition, many people complain of chronic fatigue. For example, in Japan, more than one third of the general adult population complains of chronic fatigue. It would thus be of great value to clarify the mechanisms underlying chronic fatigue and to develop efficient treatment methods to overcome it. Here, we review data primarily from behavioral, electrophysiological, and neuroimaging experiments related to neural dysfunction as well as autonomic nervous system, sleep, and circadian rhythm disorders in fatigue. These data provide new perspectives on the mechanisms underlying chronic fatigue and on overcoming it.

1 January 2017 in Medical Gas Research
Verified
Journal Article
Open access
PDF file
Yasuyoshi WatanabeYasuyoshi Watanabe
Yasuyoshi Watanabe
KMKei Mizuno
Kei Mizuno
ASAkihiro T Sasaki
Akihiro T Sasaki
KEKyoko Ebisu
Kyoko Ebisu
KTKanako Tajima
Kanako Tajima
HHHiroshi Hori
Hiroshi Hori
Health and a vibrant life are sought by everyone. To improve quality of life (QOL), maintain a healthy state, and prevent various diseases, evaluations of the effects of potentially QOL-increasing factors are important. Chronic oxidative stress and inflammation cause deteriorations in central nervous system function, leading to low QOL. In healthy individuals, aging, job stress, and cognitive load over several hours also induce increases in oxidative stress, suggesting that preventing the accumulation of oxidative stress caused by daily stress and daily work contributes to maintaining QOL and ameliorating the effects of aging. Hydrogen has anti-oxidant activity and can prevent inflammation, and may thus contribute to improve QOL. The present study aimed to investigate the effects of drinking hydrogen-rich water (HRW) on the QOL of adult volunteers using psychophysiological tests, including questionnaires and tests of autonomic nerve function and cognitive function. In this double-blinded, placebo-controlled study with a two-way crossover design, 26 volunteers (13 females, 13 males; mean age, 34.4 ± 9.9 years) were randomized to either a group administered oral HRW (600 mL/d) or placebo water (PLW, 600 mL/d) for 4 weeks. Change ratios (post-treatment/pre-treatment) for K6 score and sympathetic nerve activity during the resting state were significantly lower after HRW administration than after PLW administration. These results suggest that HRW may reinforce QOL through effects that increase central nervous system functions involving mood, anxiety, and autonomic nerve function.